タカラバイオJP:4974
時価総額
¥924.8億
PER
-10.3倍
試薬、機器、受託、遺伝子医療の各事業を展開し、PCR技術や遺伝子治療薬、再生医療製品の製造・販売を手がける企業。
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| 売上高 | 19,578 | 20,564 | 23,905 | 25,969 | 29,729 | 29,375 | 32,312 | 35,841 | 34,565 | 46,086 | 67,699 | 78,142 | 43,505 | 45,039 |
| 売上原価 | - | - | - | 12,142 | 13,405 | 12,422 | 13,657 | 15,155 | 13,459 | 14,214 | 18,488 | 33,377 | 16,597 | 18,972 |
| 売上総利益 | - | - | - | 13,827 | 16,323 | 16,952 | 18,655 | 20,685 | 21,105 | 31,872 | 49,211 | 44,765 | 26,908 | 26,067 |
| 売上総利益率（％） | - | - | - | |||||||||||
| 営業利益 | - | - | - | 2,302 | 2,667 | 3,202 | 3,555 | 5,463 | 6,274 | 13,952 | 28,902 | 20,541 | 3,003 | 2,263 |
| 営業費用 | - | - | - | 11,524 | 13,655 | 13,749 | 15,099 | 15,221 | 14,830 | 17,919 | 20,309 | 24,224 | 23,905 | 23,804 |
| 経常（税引前）利益 | 1,829 | 1,965 | 2,240 | 2,772 | 3,301 | 3,579 | 3,861 | 5,665 | 6,347 | 14,159 | 28,459 | 20,682 | 3,405 | 2,592 |
| 法人税等合計 | - | - | - | 1,521 | 1,565 | 1,449 | 1,023 | 1,149 | 1,601 | 3,971 | 7,624 | 5,176 | 1,343 | 910 |
| 純利益 | 558 | 1,422 | 1,316 | 963 | 1,340 | 1,356 | 2,338 | 3,673 | 3,831 | 9,581 | 19,908 | 16,047 | 1,510 | 1,087 |
| 一株あたり利益 | 9.06 | 12.94 | 12.5 | 8.01 | 11.08 | 11.24 | 19.39 | 30.38 | 31.72 | 79.29 | 164.84 | 132.97 | 12.3 | 8.65 |
| 希薄化後一株あたり利益 | - | 12.89 | 12.45 | - | - | - | - | - | - | - | - | - | - | - |
| 一株あたり配当金 | 1 | 1.1 | 1.2 | 1.5 | 1.8 | 4 | 4.5 | 7 | 8 | 16 | 33 | 42 | 17 | 17 |